跳至主要内容
临床试验/NCT04015570
NCT04015570Unknown不适用

A Randomized Controlled Trial to Study the Efficacy and Safety of Plasma Exchange Compared to Standard Medical Therapy in Patients With Severe Drug Induced Liver Injury With or Without Underlying Chronic Liver Disease.

Institute of Liver and Biliary Sciences, India2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年7月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
30
试验地点
2
主要终点
Transplant free survival in both group

研究概览

简要总结

In this randomized study subject will be randomized into two groups Group A will receive Standard Medical Treatment (Albumin + High Caloric Diet) Group B will continue Standard Medical Treatment with High Volume Plasma Exchange. All other interventions will be at the discretion of clinicians.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age-18-70 years
  • Preferably Biopsy proven or history suggestive of DILI (Drug Induced Liver Injury)
  • Grade IV DILI With T.B > 15
  • DILI Manifesting as ACLF (Acute on chronic Liver failure) /ALF (Acute Liver Failure) with no transplant option

排除标准

  • Evidence of active infection
  • Refusal of consent or assent
  • Patients with clinical suspicion of irreversible brain injury
  • Pregnancy
  • HCC (Hepatocellular Carcinoma) or any other malignancy
  • Kidney failure
  • Portal vein thrombosis
  • Upper GastroIntestinal bleed
  • Transplant

研究组 & 干预措施

High Volume Plasma Exchange with SMT

Experimental

PLASMA EXCHANGE is therapeutic procedure in which blood of the patient is passed through a medical device which separates plasma from other components of blood. The plasma is removed and replaced with a replacement solution such as colloid solution (e.g., albumin and/or plasma) or a combination of crystalloid/colloid solution.Plasma exchange leads to removal of abnormal circulating plasma factor or a physiologic factor produced in excess (IG, NH3,protein bond toxins )and also exert a immunomodulatory activity.

Standard Medical Treatment (Albumin + High Caloric Diet)

干预措施: High Volume Plasma Exchange (Biological)

High Volume Plasma Exchange with SMT

Experimental

PLASMA EXCHANGE is therapeutic procedure in which blood of the patient is passed through a medical device which separates plasma from other components of blood. The plasma is removed and replaced with a replacement solution such as colloid solution (e.g., albumin and/or plasma) or a combination of crystalloid/colloid solution.Plasma exchange leads to removal of abnormal circulating plasma factor or a physiologic factor produced in excess (IG, NH3,protein bond toxins )and also exert a immunomodulatory activity.

Standard Medical Treatment (Albumin + High Caloric Diet)

干预措施: Standard Medical Treatment (Other)

Standard Medical Treatment

Active Comparator

Standard Medical Treatment (Albumin + High Caloric Diet)

干预措施: Standard Medical Treatment (Other)

结局指标

主要结局

Transplant free survival in both group

时间窗: Day 28

次要结局

  • Number of participants with the development of organ dysfunction or failure in both group(Day 28)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验